Your browser doesn't support javascript.
loading
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Jiang, Yi; Guo, Lu; Han, Lei; Li, Han; Li, Changlun; Wen, Lianbin; Song, Yanqiong; Wang, Zhaoyang; Wang, Pan; Guo, Qulian; Zhao, Wenxi; Liu, Mengxiang; Chen, Jiali; Wu, Zhenying; Yan, Yushan; Xu, Ke; Gu, Tao; Wu, Xue; He, Kun; Su, Ke; Han, Yunwei.
Afiliação
  • Jiang Y; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Guo L; Department of Ophthalmology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Han L; Department of Oncology, Affiliated Hospital of Jining Medical University, Jining, 272000, China.
  • Li H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Li C; Department of Oncology, Affiliated Hospital of Jining Medical University, Jining, 272000, China.
  • Wen L; Department of Geriatric Cardiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 610072, China.
  • Song Y; Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610042, China.
  • Wang Z; Department of Medical Imaging, Southwest Medical University, Luzhou, 646000, China.
  • Wang P; Clinical Skills Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Guo Q; Department of Paediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Zhao W; Clinical Medical College, Southwest Medical University, Luzhou, 646000, China.
  • Liu M; School of Humanities and Management, Southwest Medical University, Luzhou, 646000, China.
  • Chen J; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Wu Z; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Yan Y; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Xu K; Department of Oncology, Chongqing General Hospital, Chongqing, 401147, China.
  • Gu T; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Wu X; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • He K; Clinical Research Institute, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Su K; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China. sukedsg123@163.com.
  • Han Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100000, China. sukedsg123@163.com.
J Cancer Res Clin Oncol ; 149(15): 14271-14282, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37561208
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China